Genpharmasec Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

55.37

27.69

27.69

27.69

21.69

Share application money

-

-

-

-

1.50

Preference share capital

-

-

-

-

-

Reserves & surplus

9.20

-12.36

-12.32

-7.02

-4.15

Loan funds

Secured loans

3.21

3.08

-

-

-

Unsecured loans

-

-

-

-

-

Total

67.78

18.41

15.37

20.66

19.03

Uses of funds

Fixed assets

Gross block

0.17

0.15

0.14

0.07

0.06

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.07

0.05

0.03

0.02

0.01

Net block

0.10

0.10

0.10

0.05

0.05

Capital work-in-progress

-

-

-

-

-

Investments

19.52

0.95

2.45

7.81

5.76

Net current assets

Current assets, loans & advances

50.85

18.82

19.10

19.97

18.95

Less : current liabilities & provisions

2.70

1.46

6.28

7.16

5.72

Total net current assets

48.16

17.36

12.82

12.81

13.23

Miscellaneous expenses not written

-

-

-

-

-

Total

67.78

18.41

15.37

20.66

19.03

Notes:

Book value of unquoted investments

17.84

-

-

-

-

Market value of quoted investments

1.68

-

-

-

-

Contingent liabilities

0.02

-

-

-

-

Number of equity sharesoutstanding (Lacs)

5337.20

2768.60

2768.60

276.86

216.86